| Series | TOPICS | |
|---|---|---|
| Title | First trough level of infliximab at week 2 predicts outcomes of induction therapy in ulcerative colitis -- results from a multicenter prospective randomized controlled trial and its post hoc analysis | |
| Publish Date | 2016/09 | |
| Author | Taku Kobayashi | Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
| Author | Yasuo Suzuki | Department of Internal Medicine, Toho University Sakura Medical Center |
| Author | Satoshi Motoya | Inflammatory Bowel Diseases Center, Sapporo-kosei General Hospital |
| Author | Fumihito Hirai | Department of Gastroenterology, Fukuoka University Chikushi Hospital |
| Author | Haruhiko Ogata | Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine |
| Author | Hiroaki Ito | Kinshukai Infusion Clinic |
| Author | Mamoru Watanabe | Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University |
| Author | Toshifumi Hibi | Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
| [ Summary ] | No Summary | |